investordatabase.org

Ligase BioPartners B.V.

ligasebiopartners.com Direct investor

Ligase BioPartners is a science-first life sciences investor that creates and invests in early-stage oncology companies, with a close relationship to Oncode Institute in the Netherlands. It manages the Oncode Oncology Bridge Fund I and II and supports founding teams through hands-on company building.

Ligase BioPartners B.V. is a venture capital firm headquartered in Netherlands. It invests directly in companies, from pre-seed to seed, in oncology, therapeutics, diagnostics and enabling technology.

“The fund is seeking investment opportunities at pre-seed and seed stage in Europe.”

— Ligase BioPartners B.V., own website
Layer
Direct investor
Type
Venture capital
Stage
Pre-seed – Seed
Headquarters
Netherlands
Invests in
Europe, Netherlands
Sectors
oncology, therapeutics, diagnostics, enabling technology, life sciences
How to reach it
Its contact page on its own site

Team, as Ligase BioPartners B.V. publishes it

  • Cheryl Zimberlin, Ph.D Managing Director
  • Shobhit Dhawan, Ph.D Managing Director

Names and roles exactly as listed on ligasebiopartners.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Ligase BioPartners B.V. publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 21508 · added 2026-11-12 · link last verified 2026-11-12 · confidence high

Similar investors

Listed under